Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Youngevity International Inc is a packaged foods business based in the US. Youngevity International shares (YGYI) are listed on the PINK and all prices are listed in US Dollars. Youngevity International employs 415 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$0.04|
|52-week range||$0.00 - $0.92|
|50-day moving average||$0.07|
|200-day moving average||$0.24|
|Wall St. target price||$6.00|
|Dividend yield||N/A (28.19%)|
|Earnings per share (TTM)||$-1.85|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
|1 week (2021-10-20)||100.50%|
|1 month (2021-09-27)||-19.80%|
|3 months (2021-07-27)||-81.35%|
|6 months (2021-04-27)||-86.68%|
|1 year (2020-10-27)||-95.54%|
|2 years (2019-10-25)||-99.18%|
|3 years (2018-10-26)||7|
|5 years (2016-10-27)||0.287|
|Revenue TTM||$147.4 million|
|Gross profit TTM||$94 million|
|Return on assets TTM||-27.34%|
|Return on equity TTM||-195.65%|
|Market capitalisation||$1.4 million|
TTM: trailing 12 months
There are currently 1.1 million Youngevity International shares held short by investors – that's known as Youngevity International's "short interest". This figure is 72.8% up from 648,569 last month.
There are a few different ways that this level of interest in shorting Youngevity International shares can be evaluated.
Youngevity International's "short interest ratio" (SIR) is the quantity of Youngevity International shares currently shorted divided by the average quantity of Youngevity International shares traded daily (recently around 2.6 million). Youngevity International's SIR currently stands at 0.43. In other words for every 100,000 Youngevity International shares traded daily on the market, roughly 430 shares are currently held short.
However Youngevity International's short interest can also be evaluated against the total number of Youngevity International shares, or, against the total number of tradable Youngevity International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Youngevity International's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Youngevity International shares in existence, roughly 40 shares are currently held short) or 0.0714% of the tradable shares (for every 100,000 tradable Youngevity International shares, roughly 71 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Youngevity International.
Find out more about how you can short Youngevity International stock.
We're not expecting Youngevity International to pay a dividend over the next 12 months.
Youngevity International's shares were split on a 1:20 basis on 6 June 2017. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Youngevity International shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Youngevity International shares which in turn could have impacted Youngevity International's share price.
Over the last 12 months, Youngevity International's shares have ranged in value from as little as $0.0016 up to $0.9249. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Youngevity International's is 2.2836. This would suggest that Youngevity International's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Youngevity International, Inc. develops and distributes health and nutrition related products and services in the United States and internationally. It operates in three segments: Direct Selling, Commercial Coffee, and Commercial Hemp. The company offers nutritional supplements, gourmet coffee, weight management products, skincare and cosmetics, health and wellness, packaged foods, lifestyle products, pet care, digital products, telecare health services, apparel and fashion accessories, and business lending products. It also produces and sells coffee products under the Café La Rica, Café Alma, Josie's Java House, Javalution Urban Grind, Javalution Daily Grind, and Javalution Royal Roast brands; and produces and markets a line of coffees under the JavaFit brand directly to consumers. In addition, it offers CBD oils from hemp stock. The company sells coffee and equipment to wellness and retirement communities, and various cruise lines and coffee service operators, as well as through distribution network.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.